South San Francisco, CA, United States of America

Raymond Ka Hang Tong

This inventor holds 1 USPTO granted patent and 4 published patent applications. Top assignee: Denali Therapeutics Inc.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Raymond Ka Hang Tong. Retrieved from https://idiyas.com/inventor/raymond-ka-hang-tong

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Raymond Ka Hang Tong: Innovator in Anti-HER2 Antibodies

Introduction

Raymond Ka Hang Tong is a notable inventor based in South San Francisco, CA. He has made significant contributions to the field of biotechnology, particularly in the development of anti-HER2 antibodies. His work is crucial in advancing therapeutic methods for various diseases.

Latest Patents

Raymond holds a patent titled "ANTI-HER2 ANTIBODIES AND METHODS OF USE THEREOF." This patent represents his innovative approach to targeting HER2, a protein that can promote the growth of cancer cells. His invention is a testament to his dedication to improving medical treatments.

Career Highlights

Raymond is currently employed at Denali Therapeutics Inc., a company known for its focus on developing therapies for neurodegenerative diseases. His role at Denali Therapeutics allows him to collaborate with other talented professionals in the field, enhancing the impact of his work.

Collaborations

Raymond has worked alongside esteemed colleagues, including Allisa Jayne Clemens and Do Jin Kim. These collaborations have fostered a productive environment for innovation and research.

Conclusion

Raymond Ka Hang Tong is a distinguished inventor whose work in anti-HER2 antibodies is paving the way for advancements in medical therapies. His contributions to biotechnology are invaluable, and his ongoing efforts continue to inspire progress in the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…